Built on the science of what watching closely actually changes.
Omelo exists because a founder lost two dogs to something that could have been caught earlier. Everything since has been one clinical argument: what if the intelligence existed every day, not just at the vet?
“I lost two dogs to parvo. The clinics were closed. I had nothing to decode the symptoms. If something had been watching alongside me that night, they might still be here.”
Omelo was not built from a market analysis or a pitch-deck thesis. It was built from the specific, irreversible loss that comes from not knowing, until it is too late to act.
The average pet sees a veterinarian twice a year. That leaves 363 days where the only one watching is you, without tools, without context, without clinical intelligence. Omelo exists for those 363 days.
The ones we love most are the ones who cannot tell us what hurts.
They greet us at the door, sleep at our feet, and quietly carry whatever is wrong. Knowing them, every day, is the closest thing to hearing them speak.
A billion pets, the same blind spot in every country.
More than a billion dogs and cats live in our homes. Across every market they share one blind spot: a professional sees them a few days a year, and the other 360-plus fall to the parent. What changes by country is mostly how much the safety net costs you when something goes wrong.
The safety net is thin, and wildly unequal.
Pet health insurance is the closest thing to a financial backstop, and the share of pets covered swings from almost everyone to almost no one depending on where you live.
Approximate share of pets insured by country; methodology varies by market (dogs, cats, and households are measured differently). Sources: Agria (Sweden), FEDIAF (Europe), NAPHIA (United States), and national pet-insurance market reports, 2024 to 2025.
Wherever your pet lives, the math holds. The vet sees them a few days a year, the safety net is thin or absent, and the cost of catching something late, in money and in life, lands on you. Daily observation is the one intervention that scales to every home, in every country.
Five things no other product does.
With the published science behind each one. Not marketing claims, clinical arguments, each grounded in veterinary research.
Your pet hides their pain. Omelo measures around it.
Pets conceal illness. This is not a behavioral quirk, it is a deep evolutionary program. In the wild, the animal that showed weakness got left behind. Every domestic pet runs that survival instinct inside your home, every single day.
The clinical consequence: a dog with early kidney disease does not limp, and a cat with early hyperthyroidism does not cry out. They adjust. They compensate. They hide. By the time the signs become impossible to ignore, the disease is no longer early.
Omelo does not try to see through the concealment. It watches the subtle deviations that happen around it, appetite, activity, sleep, hydration, and detects the change from normal before the concealment becomes complete.
Behavioral signals arrive before the blood test knows.
This is the clinical argument the blood-testing model does not name. Behavioral deviation precedes biochemical deviation. An appetite change precedes an abnormal blood panel. Lethargy precedes elevated inflammatory markers.
The loss of normal behaviors, decreased activity, reduced appetite, altered sleep, are the primary signals that precede measurable biological change, across conditions from hypothyroidism to GI disease to early oncology.
A blood test catches what has already become measurable. Behavioral observation catches what is becoming. Omelo operates upstream of the laboratory: by the time a panel shows abnormal kidney markers, Omelo has already seen weeks of appetite and hydration change.
Your pet's normal is not other pets' normal.
Population averages are clinically inadequate for an individual animal. A Labrador that normally eats 400g a day and drops to 280g has shown a meaningful appetite decline. The same intake in another Labrador might be perfectly normal. The number is not the signal. The deviation from individual normal is the signal.
After about thirty days of daily engagement, Omelo has established this pet's baseline, not the breed's. Their normal appetite range, their normal activity, their normal sleep. Every later deviation is measured against this animal's own prior self, not a population average.
Two small things declining together is not two problems. It is one.
A single symptom is a data point. Two declining at the same time is a pattern. The difference is the difference between noise and signal.
In human emergency medicine, clinical scoring systems, the qSOFA score for sepsis, the Wells score for embolism, are built on a simple principle: the co-occurrence of multiple indicators carries far greater diagnostic weight than any single one alone. The convergence of signals is the signal.
Omelo watches for that convergence across days and across systems. An appetite falling while vomiting rises, two lines crossing on a chart, is not two problems. It is one problem getting worse, and Omelo sees the crossing before the parent sees the crisis.
Purpose-built clinical reasoning beats a general assistant.
The market misreads what makes an AI clinically useful for pet health. The assumption is that a better language model produces better guidance. The limiting factor is not the model. It is the reasoning architecture and the specificity of the input.
In a 2025 blind comparison, veterinarians judged purpose-built veterinary AI more accurate, more thorough, and safer than a general assistant. Not because the general model is unintelligent, but because clinical reasoning needs structured, sequential questioning rather than open-ended conversation.
Omelo is built on that purpose-built approach: clinical reasoning runs before a single visible word, against a library of vet-built decision trees, with a memory of what has and has not worked for your specific animal.
Clinical reasoning runs before Omelo says anything.
Underneath the conversation is a clinical decision-support system, not a chatbot with a good prompt. Three principles hold it together.
The reasoning architecture is the difference, not the model.
Most people assume a larger, smarter model means smarter medicine. It does not. Clinical reliability comes from how a system reasons, not how big it is. Human medicine settled this long ago: decision support earns trust through structured, step-by-step logic that can be checked, never through fluent guesswork. Omelo holds your pet's case to that same standard, working through history, baseline, and red flags in sequence before it says a word.
Tens of thousands of conversations. One lesson.
Since launch, Omelo has had tens of thousands of real health conversations with pet parents across 15+ countries, with no paid acquisition. The patterns are consistent.
Amogh Tiwari
Omelo began with a loss Amogh could not undo. A design engineer by craft, he is building the daily clinical intelligence he wishes he had the night his dogs needed it, the kind that watches the quiet days, not just the emergencies.
The clinical reasoning is built with practicing veterinarians, so the guidance holds up under the same scrutiny a vet would bring to the room.
Every pet deserves to be understood, not just reacted to.
Not for the one percent who can afford annual blood panels and specialists. For every parent, every pet, every day. A dog in Bengaluru and a cat in Brooklyn. A rescue in Mumbai and a puppy in San Francisco. All of them deserving the same quality of care.
Omelo is building toward a world where daily observation is automatic, continuous, and clinically intelligent, where the 363 days between vet visits are never silent again. Where catching something early is not luck. It is infrastructure.
Start knowing your pet →
Omelo does not provide veterinary diagnosis. All clinical guidance is for informational purposes and should be used alongside, not as a replacement for, professional veterinary care.